Author(s): Sini T. Inasu, M.V. Kumudavalli, B.S. Venkateswarlu

Email(s): siniinasu09@gmail.com

DOI: 10.52711/0974-360X.2022.00888   

Address: Sini T. Inasu*, M.V. Kumudavalli, B.S. Venkateswarlu
1Assistant Professor, Department of Pharmacy Practice, Ahalia School of Pharmacy, Palakkad, Kerala- 678557, India.
2MV. Kumudavalli, Professor, Department of Pharmacy, Vinayaka Missions College of Pharmacy, Vinayaka Mission’s Research Foundation (Deemed University) Salem, Tamil Nadu- 636008, India.
3BS Venkateswarlu, Principal, Department of Pharmacy, Vinayaka Missions College of Pharmacy, Vinayaka Mission’s Research Foundation (Deemed University) Salem, Tamil Nadu- 636008, India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 11,     Year - 2022


ABSTRACT:
Pharmacy practice has moved from medication delivery to a patient-focused approach during the last four decades. The pharmacist role has shifted from a compounding pharmacist and distributor of pharmaceuticals to one of the services and finally to a care provider. Progressively, the pharmacist's job is to ensure that the patient's medication is adequate and the best possible and readily available. Pharmacists can depend on the personal needs of their patients, thus making an essential contribution to drug therapy outcomes and quality of life. The number of people affected by diabetes and the costs associated with its management is relatively high worldwide, especially in developing countries like India. Aside from contributing to the financial strain, the problems arising from delays in detection and management are numerous. Clinical pharmacists have been inducted as important healthcare team members in many developing countries medical centers. This article discusses the role of the clinical pharmacist in the treatment of diabetes mellitus, including drug therapy, diabetes care, and education. The main aim of treatment in diabetes treatment has been to optimize drug therapy to achieve improved clinical results without causing drug-related issues. Clinical pharmacists who are well-trained and readily available are key healthcare practitioners who can help patients achieve improved drug treatment outcomes.


Cite this article:
Sini T. Inasu, M.V. Kumudavalli, B.S. Venkateswarlu. Clinical Pharmacist role and their Importance in the Systematic Analysis of Diabetes Management Studies. Research Journal of Pharmacy and Technology. 2022; 15(11):5273-7. doi: 10.52711/0974-360X.2022.00888

Cite(Electronic):
Sini T. Inasu, M.V. Kumudavalli, B.S. Venkateswarlu. Clinical Pharmacist role and their Importance in the Systematic Analysis of Diabetes Management Studies. Research Journal of Pharmacy and Technology. 2022; 15(11):5273-7. doi: 10.52711/0974-360X.2022.00888   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-11-73


REFERENCES:
1.    Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012;18(7):516-526. doi:10.18553/jmcp.2012.18.7.516.
2.    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
3.    American Diabetes Association. Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers. Clin Diabetes. 2017;35(1):5-26. doi:10.2337/cd16-0067.
4.    Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials. J Manag Care Spec Pharm. 2016;22(5):493-515. doi:10.18553/jmcp.2016.22.5.493.
5.    Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes. 2010; 8:18. Published 2010 Feb 4. doi:10.1186/1477-7525-8-18.
6.    Ibrahim khalid Rayes I, Abrika O. In-patient and Out-patient Pharmacist Intervention in the Management of Diabetes Mellitus Conditions in Dubai, United Arab Emirates: A Qualitative Approach. Res. Pharm. Heal. Sci. 2017: 3; 303–307. doi: 10.32463/rphs. 2017.v03i02.09
7.    Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011. doi:10.1002/14651858.CD000011.
8.    https://www.who.int/mediacentre/news/new/2006/nw05/en/.
9.    Dorevitch A, Perl E. The impact of clinical pharmacy intervention in a psychiatric hospital. J Clin Pharm Ther. 1996;21(1):45-48. doi:10.1046/j.1365-2710.1996.89575895. x.
10.    Hasan S, Sulieman H, Stewart K, Chapman CB, Hasan MY, Kong DC. Assessing patient satisfaction with community pharmacy in the UAE using a newly-validated tool. Res Social Adm Pharm. 2013;9(6):841-850. doi: 10.1016/j.sapharm.2012.10.002.
11.    Côté I, Moisan J, Chabot I, Grégoire JP. Health-related quality of life in hypertension: impact of a pharmacy intervention programme. J Clin Pharm Ther. 2005;30(4):355-362. doi:10.1111/j.1365-2710.2005.00663.x.
12.    Ayadurai S, Hattingh HL, Tee LB, Md Said SN. A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists. J Diabetes Res. 2016;2016:5897452. doi:10.1155/2016/5897452.
13.    Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26(5):1421-1426. doi:10.2337/diacare.26.5.1421.
14.    https://www.who.int/health-topics/diabetes#tab=tab_1.
15.    www.expertmarketresearch.com/reports/indian-diabetes-market.
16.    https://idf.org/our-network/regions-members/south-east-asia/members/94-india.html.
17.    https://www.cdc.gov/diabetes/data/statistics-report/index.html
18.    Calvert RT. Clinical pharmacy--a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231-238. doi:10.1046/j.1365-2125.1999.00845.x.
19.    Alotaibi YK, Federico F. The impact of health information technology on patient safety. Saudi Med J. 2017;38(12):1173-1180. doi:10.15537/smj.2017.12.20631.
20.    Sanii Y, Torkamandi H, Gholami K, Hadavand N, Javadi M. Role of pharmacist counseling in pharmacotherapy quality improvement. J Res Pharm Pract. 2016;5(2):132-137. doi:10.4103/2279-042X.179580.
21.    Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275-280. doi:10.1111/j.1742-7843.2007.00206.x.
22.    Shareef, Javedh, Jennifer Fernandes, Laxminarayana Samaga. "Evolving role of clinical pharmacist in the management of diabetes mellitus." International Journal of Research in Medical Sciences [Online], 3.6 (2015): 1305-1308. doi: http://dx.doi.org/10.18203/2320-6012.ijrms20150136.
23.    Venkatesan R, Devi AS, Parasuraman S, Sriram S. Role of community pharmacists in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res. 2012;3(1):26-31. doi:10.4103/2229-3485.92304.
24.    Smith M. Pharmacists' role in improving diabetes medication management. J Diabetes Sci Technol. 2009;3(1):175-179. doi:10.1177/193229680900300120.
25.    Iqbal MZ, Khan AH, Iqbal MS, Syed Sulaiman SA. A Review of Pharmacist-led Interventions on Diabetes Outcomes: An Observational Analysis to Explore Diabetes Care Opportunities for Pharmacists. J Pharm Bioallied Sci. 2019;11(4):299-309. doi:10.4103/jpbs.JPBS_138_19.
26.    Syarifuddin S, Nasution A, Dalimunthe A, Khairunnisa. Impact of Pharmacist Intervention on Improving the Quality of Life of Patients with Type 2 Diabetes Mellitus. Open Access Maced J Med Sci. 2019; 7(8):1401-1405. doi:10.3889/oamjms.2019.140.
27.    Dunlap E, Johnson BD, Kotarba JA, Fackler JL. Macro-level social forces and micro-level consequences: poverty, alternate occupations, and drug dealing. J Ethn Subst Abuse. 2010;9(2):115-127. doi:10.1080/15332641003772611.
28.    Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017; 6:37-46. doi:10.2147/IPRP.S108047.
29.    Ghaibi S, Ipema H, Gabay M; American Society of Health System Pharmacists. ASHP guidelines on the pharmacist's role in providing drug information. Am J Health Syst Pharm. 2015;72(7):573-577. doi:10.2146/sp150002.
30.    Masic I, Miokovic M, Muhamedagic B. Evidence based medicine - new approaches and challenges. Acta Inform Med. 2008;16(4):219-225. doi:10.5455/aim.2008.16.219-225.
31.    Mukesh K, Satish P, Shikha S, S.J. Daharwal, Manju RS, Deependra S. An Overview on Diabetes Mellitus with Emphasis on Non-Invasive Techniques of Insulin Delivery. Research J. Science and Tech; 5(4):387-395. doi: 10.5958/2349-2988.
32.    Merry R, Vijayanarayana K, GirishT, Karthik R N, Sreedharan N. Utilization Pattern of Anti-Diabetic Drugs in Type 2 Diabetes Mellitus in Tertiary Care Hospital. Research J. Pharm. and Tech. 2017; 10(7): 2063-2068. doi: 10.5958/0974-360X.2017.00360.2.



Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available